CANbridge is actively seeking partnerships with global bio-pharmaceutical companies and academic institutions.
CANbridge has the capability to select, acquire, develop and commercialize future 
therapeutics and diagnostics targeting seriously unmet medical needs 
of Chinese and East Asians.

We are focusing  on opportunities in following areas:
● In-licensing or co-development of clinical-stage product candidates on indications highly relevant to Chinese and Asians
● Commercialization of orphan and other specialty products in China, Taiwan and Korea                                                      


For more, please contact our business development team via e-mail at

本网站由阿里云提供云计算及安全服务 Powered by CloudDream